Evidence map›Paper›PMID 35216234›Full record

ReviewInternational journal of molecular sciences2022

Atopic Dermatitis: The Fate of the Fat.

Petra Pavel, Stefan Blunder, Verena Moosbrugger-Martinz, Peter M Elias, Sandrine Dubrac

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Therapeutic Potential of Ceramide in Cancer Treatment.Journal of cancer research and oncobiology · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Petra PavelDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Stefan BlunderDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Verena Moosbrugger-MartinzDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Peter M EliasDepartment of Dermatology, University of California, San Francisco, CA 94115, USA.ORCID 0000-0001-7989-4032
Sandrine DubracDepartment of Dermatology, Venereology and Allergology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.ORCID 0000-0002-2936-8488
Innsbruck Medical University · ATUniversity of California, San Francisco · US

Funding

Austrian Science Fund FWF P 31662
6 · The paper itself

Abstract

Atopic dermatitis (AD) is a chronic and relapsing inflammatory skin disease in which dry and itchy skin may develop into skin lesions. AD has a strong genetic component, as children from parents with AD have a two-fold increased chance of developing the disease. Genetic risk loci and epigenetic modifications reported in AD mainly locate to genes involved in the immune response and epidermal barrier function. However, AD pathogenesis cannot be fully explained by (epi)genetic factors since environmental triggers such as stress, pollution, microbiota, climate, and allergens also play a crucial role. Alterations of the epidermal barrier in AD, observed at all stages of the disease and which precede the development of overt skin inflammation, manifest as: dry skin; epidermal ultrastructural abnormalities, notably anomalies of the lamellar body cargo system; and abnormal epidermal lipid composition, including shorter fatty acid moieties in several lipid classes, such as ceramides and free fatty acids. Thus, a compelling question is whether AD is primarily a lipid disorder evolving into a chronic inflammatory disease due to genetic susceptibility loci in immunogenic genes. In this review, we focus on lipid abnormalities observed in the epidermis and blood of AD patients and evaluate their primary role in eliciting an inflammatory response.

Indexed as

AnimalsDermatitis, AtopicEpidermisFatsHumansInflammationLipidsFatsLipidsatopic dermatitisceramideseczemaeicosanoidsepidermal barrierfilaggrinlipids

Identifiers

PMID35216234
PMCPMC8880331
OpenAlexW4212815636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.